TrialNature medicine2025

Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial.

Song-Yang Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.